Mesoblast

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Mesoblast and other ETFs, options, and stocks.

About MESO

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. 

CEO
Silviu Itescu
CEOSilviu Itescu
Employees
77
Employees77
Headquarters
Melbourne, Victoria (VIC)
HeadquartersMelbourne, Victoria (VIC)
Founded
2004
Founded2004
Employees
77
Employees77

MESO Key Statistics

Market cap
406.59M
Market cap406.59M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
85.26K
Average volume85.26K
High today
$2.88
High today$2.88
Low today
$2.63
Low today$2.63
Open price
$2.79
Open price$2.79
Volume
213.94K
Volume213.94K
52 Week high
$7.28
52 Week high$7.28
52 Week low
$2.14
52 Week low$2.14

MESO News

MarketWatch 16h
Mesoblast Shares Rise 10% After New Info Submitted to FDA for Remestemcel-L - MarketWatch

By Chris Wack Mesoblast Ltd. shares were up 10% to $2.80 after the company said it submitted substantial new information to the U.S. Food and Drug Administrati...

Mesoblast Shares Rise 10% After New Info Submitted to FDA for Remestemcel-L - MarketWatch

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
0%
Sell
14.3%

MESO Earnings

-$0.22
-$0.15
-$0.07
$0.00
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Estimated
per share
Estimated per share
Actual
Expected Nov 23
ActualExpected Nov 23
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.